Friday November 27 2009 | Biotechnology feed | All feeds
|
|
Tragen Pharmaceuticals
Download detailed PDF Members: Tragen Pharmaceuticals (formerly Immunogenex, Inc.) is developing a family of potent biotherapeutics for the treatment of disease. At the core of Tragen's proprietary technology are recombinant forms of the tumor necrosis factor (TNF) family of molecules. Coupled with our expertise in gene delivery systems, we are creating an effective and sustainable approach for treating disease.
This page has been viewed 611 times since April 2007, the link to the organisation's website has been followed 130 times Recent Search Terms used to find this page: tragen pharmaceuticals | Noah D. Beerman email | tragen pharmaceuticals | tragen pharmaceuticals | tryagen pharmaceuticals | tragen pharmaceuticals | Tragen Pharmaceutical san diego | Tragen Pharmaceuticals | Tragen Pharmaceuticals | Tragen Pharmaceuticals | . Search for more companies in San Diego Search for more companies in California This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Tragen Pharmaceuticals | |||||||||||||||||||||||||||||||||||||||||
|